| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
69,020,000 |
| Market
Cap: |
106.29(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.6003 - $3.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NGM Biopharmaceuticals is a biopharmaceutical company. Co. has five product candidates in the clinic, three wholly-owned by Co. (NGM707, NGM120 and aldafermin), one being progressed by its collaborator, Merck Sharp & Dohme Corp., or Merck (MK-3655) and one optionable by Merck (NGM621). Co.'s oncology product candidates include NGM707, NGM831, NGM438 and NGM120 and their related compounds. NGM621 was engineered to bind to, and be a long-acting inhibitor of, complement C3 with the treatment goal of reducing disease progression in patients with geographic atrophy, secondary to age-related macular degeneration. MK-3655 isin Phase 2b development for the treatment of nonalcoholic steatohepatitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
94,704 |
7,518,862 |
| Total Buy Value |
$0 |
$0 |
$64,854 |
$66,954,067 |
| Total People Bought |
0 |
0 |
4 |
5 |
| Total Buy Transactions |
0 |
0 |
10 |
94 |
| Total Shares Sold |
0 |
0 |
0 |
85,082 |
| Total Sell Value |
$0 |
$0 |
$0 |
$438,308 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Svennilson Peter |
10% Owner |
– – • |
2019-10-09 |
4 |
B |
$10.26 |
$181,848 |
I/I |
17,724 |
16,184,631 |
1.5 |
- |
|
| Column Group Iii Gp, Lp |
General Partner |
– – • |
2019-10-09 |
4 |
B |
$10.26 |
$181,848 |
D/D |
17,724 |
17,724 |
2.45 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-10-09 |
4 |
B |
$10.26 |
$181,848 |
D/D |
17,724 |
17,724 |
2.45 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-08-09 |
4 |
B |
$13.99 |
$2,126 |
D/D |
152 |
2,597,816 |
2.37 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-09 |
4 |
B |
$13.99 |
$2,126 |
I/I |
152 |
16,356,907 |
2.17 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-09 |
4 |
B |
$13.99 |
$2,126 |
I/I |
152 |
16,166,907 |
2.17 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-08-08 |
4 |
B |
$13.98 |
$168 |
D/D |
12 |
2,597,664 |
2.37 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-08 |
4 |
B |
$13.98 |
$168 |
I/I |
12 |
16,356,755 |
2.17 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-08 |
4 |
B |
$13.98 |
$168 |
I/I |
12 |
16,166,755 |
2.17 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-08-07 |
4 |
B |
$14.00 |
$3,143,000 |
D/D |
224,500 |
2,597,652 |
2.45 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-07 |
4 |
B |
$14.00 |
$3,143,000 |
I/I |
224,500 |
16,356,743 |
2.25 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-07 |
4 |
B |
$14.00 |
$3,143,000 |
I/I |
224,500 |
16,166,743 |
2.25 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-08-06 |
4 |
B |
$13.96 |
$4,328 |
D/D |
310 |
2,373,152 |
2.37 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-06 |
4 |
B |
$13.96 |
$4,328 |
I/I |
310 |
15,942,243 |
2.17 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-06 |
4 |
B |
$13.96 |
$4,328 |
I/I |
310 |
16,132,243 |
2.17 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-08-05 |
4 |
B |
$13.98 |
$81,400 |
D/D |
5,824 |
2,372,842 |
2.45 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-05 |
4 |
B |
$13.98 |
$81,400 |
I/I |
5,824 |
15,941,933 |
2.25 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-05 |
4 |
B |
$13.98 |
$81,400 |
I/I |
5,824 |
16,131,933 |
2.25 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-02 |
4 |
B |
$13.97 |
$24,898 |
I/I |
1,782 |
16,126,109 |
2.17 |
- |
|
| Column Group Ii Gp, Lp |
General Partner |
– – • |
2019-08-02 |
4 |
B |
$13.97 |
$24,898 |
D/D |
1,782 |
2,367,018 |
2.37 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-02 |
4 |
B |
$13.97 |
$24,898 |
I/I |
1,782 |
15,936,109 |
2.17 |
- |
|
| Goeddel David V |
Director |
– • • |
2019-08-01 |
4 |
B |
$13.98 |
$36,346 |
I/I |
2,600 |
16,124,327 |
2.25 |
- |
|
| Column Group Ii Gp, Lp |
General Partner |
– – • |
2019-08-01 |
4 |
B |
$13.98 |
$36,346 |
D/D |
2,600 |
2,365,236 |
2.37 |
- |
|
| Svennilson Peter |
Director |
– • • |
2019-08-01 |
4 |
B |
$13.98 |
$36,346 |
I/I |
2,600 |
15,934,327 |
2.25 |
- |
|
| Kutzkey Tim |
Managing Partner |
– – • |
2019-07-30 |
4 |
B |
$13.91 |
$123,195 |
D/D |
8,855 |
2,362,636 |
2.45 |
- |
|
499 Records found
|
|
Page 16 of 20 |
|
|
